EUVIMEDEUVIMED entdecken
Crossref

Protease-Triggered, Spatially Controlled DNA Assembly in Apoptotic Cells for Early Evaluation of Therapeutic Efficacy

Zhenghan Di, Xiulin Yi, Lele Li iD

Journal of the American Chemical Society · 2023

DOI: 10.1021/jacs.2c13214 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Chemical Society, 2023. Verfasst von Zhenghan Di und 2 weiteren Autor:innen. Beteiligte Einrichtung: CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, National Center for Nanoscience and Technology, Beijing 100190, China. Hauptthemen laut MEDLINE: Peptide Hydrolases, Neoplasms. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Chinese Academy of Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite numerous advances in the use of DNA as building blocks to assemble complex structures, the dearth of strategies that allow for protease-controlled in situ DNA assembly in living cells remains a bottleneck in this field. Here, we present a modular engineering approach to achieve protease-triggered self-assembly of DNA in apoptotic cells for early evaluation of tumor response to drug treatment. In the design, peptide nucleic acid is introduced as a building bridge to engineer DNA building blocks with peptides and thus to suppress their self-assembly activity, while caspase-3 (Casp-3) protease-mediated enzymatic cleavage of the peptide substrate enables the activation of the DNA assembly, generating fluorescence signal output for real-time monitoring of Casp-3 activity. Furthermore, the specific protease triggering imparts DNA assembly with spatial selectivity to apoptotic cells in vivo, allowing for early evaluation of tumor therapeutic efficacy. Moreover, the strategy is extended to probe the activity of MMP-2 for lymph node metastasis imaging, demonstrating the universality of this approach. This work highlights protease-controlled DNA assembly in ways that are simple and versatile, with the potential to expand the repertoire of DNA nanotechnology for diverse biomedical applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Peptide HydrolasesNeoplasmsHumansNanotechnologyDNAPeptidesEndopeptidasesApoptosis

Substanzen

Peptide HydrolasesDNAPeptidesEndopeptidases

Autor:innen und Institutionen

  • CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, National Center for Nanoscience and Technology, Beijing 100190, China.
  • College of Materials Science and Optoelectronic Technology, University of Chinese Academy of Sciences, Beijing 100049, China.

ORCID-Profile: Lele Li

Förderung

  • National Natural Science Foundation of China
  • Chinese Academy of Sciences

Zitieren

APA

Di, Z., Yi, X., & Li, L. (2023). Protease-Triggered, Spatially Controlled DNA Assembly in Apoptotic Cells for Early Evaluation of Therapeutic Efficacy. Journal of the American Chemical Society. https://doi.org/10.1021/jacs.2c13214

Vancouver

Di Z, Yi X, Li L. Protease-Triggered, Spatially Controlled DNA Assembly in Apoptotic Cells for Early Evaluation of Therapeutic Efficacy. Journal of the American Chemical Society. 2023. doi:10.1021/jacs.2c13214

BibTeX
@article{Di2023,
  author = {Di, Zhenghan and Yi, Xiulin and Li, Lele},
  title = {Protease-Triggered, Spatially Controlled DNA Assembly in Apoptotic Cells for Early Evaluation of Therapeutic Efficacy},
  journal = {Journal of the American Chemical Society},
  year = {2023},
  doi = {10.1021/jacs.2c13214}
}
Kostenlos starten →